Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.

Corticosteroid therapy of alcoholic hepatitis. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Serum-ascites albumin gradient in differential diagnosis of ascites. Uddin MS, Hoque MI, Islam MB, Uddin MK, Haq I, Mondol G, Tariquzzaman M. Evidence-based incorporation of serum sodium concentration into MELD. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. OPTN's announcement about Sodium Inclusionģ. A model to predict survival in patients with end-stage liver disease. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. The range of results is presented with its corresponding 3-month mortality percentage (based on original MELD).

Sodium values less than 125 mmol/L will be set to 125, and values greater than 137 mmol/L will be set to 137.

The upper limit for serum creatinine is 4 mg/dL, therefore for those patients that have had 2 rounds of dialysis in the past week, the value is automatically adjusted to 4 mg/dL.

Values less than 1 are automatically adjusted to the lower limit value of 1 to prevent obtaining a negative score.

Please note the calculator also accounts for the following adjustments: Therefore, the new formula where original MELD score is MELD(i) is: In January 2016, OPTN changed Policy 9.1 in regard to the calculation of the MELD score to include serum sodium.

Original MELD Score (rounded) = 10 x + 6.43.

The MELD score assesses the severity of the chronic liver disease and is used in the liver transplant waiting list prioritization by the United Network for Organ Sharing (UNOS). This data can then be used, along with others such as serum sodium or platelet count and subject age, gender, height and weight, to compute several hepatic parameters and scores that evaluate liver function, signs of liver disease or even differentiate between different manifestations of liver conditions. An increase in this time may be due to blood thinning warfarin treatment or liver damage. This is a serum enzyme whose high levels indicate liver or bile duct damage. This is an enzyme that metabolizes amino acids. Hepatic damage results in high ALT levels released in bloodstream. This is an enzyme that converts proteins into energy in the liver cells. High bilirubin levels (jaundice) indicate liver damage.

Lower levels may indicate liver damage.īilirubin is one of the waste products of red blood cell breakdown, processed by the liver before stool release. This is one of the proteins produced by the liver with different roles in the body. The table below summarizes the main liver function enzymes and proteins that are tested: Hepatic indicator

LFTs may be required following symptoms such as jaundice, nausea and vomiting, abdominal pain, diarrhoea, dark-coloured urine, light-coloured stool or persistent unexplained fatigue.

Monitoring possible side effects of medication (due to liver clearance).

Measuring severity of hepatic damage (particularly scarring of the liver in cirrhosis).Monitoring progression of hepatic disease and reaction to treatment.Screening for liver infections, such as hepatitis.Liver function test is a term usually used to refer to the blood tests that measure different enzymes, proteins, and other substances made by the liver (such as albumin, bilirubin, AST or ALT).

Enzymex calculator